|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
BeerYaakov Mental Health Center Ebetim Clinic |
|---|---|
| Information provided by: | BeerYaakov Mental Health Center |
| ClinicalTrials.gov Identifier: | NCT00687089 |
Purpose
People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.
The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.
The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports)
| Condition | Intervention |
|---|---|
|
Opiate Addiction |
Other: Sexual, cognitive functional tests and measurement weight |
| Study Type: | Observational |
| Study Design: | Case-Only, Prospective |
| Official Title: | Examination of Cognitive Function, Weight, Sexual Function in Patients Receiving Treatment With Subutex at 3 Months Without Using Opiates |
| Estimated Enrollment: | 60 |
| Study Start Date: | June 2008 |
| Estimated Study Completion Date: | January 2009 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Subutex group
People who used opiates and willing to start with subutex treatment
|
Other: Sexual, cognitive functional tests and measurement weight |
People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.
The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.
The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports) We examine people who stopped opiates and began Buprenorphine. Every participant in the study will have two visits: the first one before receiving Buprenorphine and the second one after 3 months of receiving Buprenorphine.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
People who suffer from addiction problems (opiates) and willing to start Buprenorphine treatment
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Responsible Party: | "Hebetim" psychiatric and psychologic clinic- private clinic ( Aviva Wolf ) |
| Study ID Numbers: | Subutex-214CTIL |
| Study First Received: | May 27, 2008 |
| Last Updated: | June 1, 2008 |
| ClinicalTrials.gov Identifier: | NCT00687089 |
| Health Authority: | Israel: Ministry of Health |
|
Opiates Subutex Buprenorphine Patients who addicted to opiates |
|
Body Weight Buprenorphine Behavior, Addictive Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Opioid-Related Disorders |
|
Sensory System Agents Therapeutic Uses Narcotic Antagonists Physiological Effects of Drugs Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions Analgesics, Opioid |
